Literature DB >> 8506208

The renal effects of dopamine and dobutamine in stable chronic heart failure.

O M Jolobe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8506208      PMCID： PMC2399640          DOI： 10.1136/pgmj.69.808.165

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial).

Authors:  S Ljungman; J Kjekshus; K Swedberg
Journal:  Am J Cardiol       Date:  1992-08-15       Impact factor: 2.778

2.  Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.

Authors:  M A Creager; J L Halperin; D B Bernard; D P Faxon; C D Melidossian; H Gavras; T J Ryan
Journal:  Circulation       Date:  1981-09       Impact factor: 29.690

3.  Captopril and the diuretic requirements in moderate and severe chronic heart failure.

Authors:  O Odemuyiwa; J Gilmartin; D Kenny; R J Hall
Journal:  Eur Heart J       Date:  1989-07       Impact factor: 29.983

4.  Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure.

Authors:  M Packer; W H Lee; N Medina; M Yushak; P D Kessler
Journal:  Ann Intern Med       Date:  1987-03       Impact factor: 25.391

5.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.

Authors:  M A Konstam; M F Rousseau; M W Kronenberg; J E Udelson; J Melin; D Stewart; N Dolan; T R Edens; S Ahn; D Kinan
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

6.  Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.

Authors:  V J Dzau; W S Colucci; G H Williams; G Curfman; L Meggs; N K Hollenberg
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.